Proton-pump inhibitors and risk of fractures: an update meta-analysis.
about
Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System.Influence of proton pump inhibitors and histamine H2 receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review.Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.Osteoporosis Management in Ankylosing Spondylitis.The Italian Society of Internal Medicine choosing wisely campaign.Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438).Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors.Use of proton pump inhibitors and mortality after hip fracture in a nationwide study.Proton Pump Inhibitors and Kidney Disease - GI Upset for the Nephrologist?Risk of death among users of Proton Pump Inhibitors: a longitudinal observational cohort study of United States veterans.Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure PatientsPantoprazole, a proton pump inhibitor, does not prevent botulinum toxin induced disuse osteopenia in mice.Incidence and predictors of osteoporotic fractures in patients with Barrett's oesophagus: a population-based nested case-control study.Editorial: Non-breaking news! High-dose PPIs likely do not cause fractures.Letter: proton pump inhibitor use and fracture risk.Adverse bone effects of medications used to treat non-skeletal disorders.The effect of hypergastrinemia following sleeve gastrectomy and pantoprazole on type 2 diabetes mellitus and beta-cell mass in Goto-Kakizaki rats."First Do No Harm": Adverse Events from Pharmaceutical Treatment of Gastroparesis and Dyspepsia.A retrospective analysis of bone mineral status in patients requiring spinal surgery.Evidence of Drug-Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update.Internists' Perceptions of Proton Pump Inhibitor Adverse Effects and Impact on Prescribing Practices: Results of a Nationwide Survey.Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine.Proton-pump inhibitors among adults: a nationwide drug-utilization study.Self-Reported Fractures in Dermatitis Herpetiformis Compared to Coeliac Disease.Safe use of proton pump inhibitors in patients with cirrhosis.Proton Pump Inhibitors: Are They a Real Threat to the Patient?Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
P2860
Q33912042-F317B755-00B3-431C-80B6-FAEF1F08E6A7Q37431931-55244F42-9A29-41E1-BC80-7F794B9E6105Q38610883-534F3B87-35E1-47C8-8F37-697196F288A5Q38670399-84B7D337-1786-456F-88C3-36B380ED6253Q38800531-115246E7-00C9-46D3-8941-6D117A001E3FQ38861693-47D2F1BC-16C1-4B25-9DFE-21EC20274CFBQ38865456-4C620583-B61B-4F1E-837B-C005118BE1DAQ38955844-2E8395B7-A263-49EB-B457-6C5AC29DDAFAQ39023035-0F7DE665-7352-4F12-911C-27977D8F7C55Q40068373-5286E9F6-3944-463D-997B-3D3A16F4D0EDQ40135306-C4797CE4-BBA1-4561-B0BA-3C2DF9DD500FQ40475429-58D88BDF-6A7E-4E8F-81B4-AFA33179259FQ41104304-46AD3F09-9510-4A9E-A17B-549601B5F9CDQ41707081-977BAAE2-C86D-4160-8916-985CBDF2FEB3Q47619259-C97DEE69-2872-4F67-A349-3E43834E3684Q48144693-E7C73DBB-2C52-4E13-A502-B18485882755Q48288782-8666A711-3CC9-4A1B-A2E6-CABBA1580B5AQ48332195-6E27F5A0-4ABA-4D5B-8639-9C9A340ECD63Q49721049-6B4C0B26-A9B6-4847-8292-ACD0317A44ACQ49971426-C0443A94-6AAA-482E-8D57-C5CA093534CEQ50032659-7DB8AFFA-F83D-4FB4-A460-C6D2F6306A2DQ51761248-87C54C39-7A64-4D89-AC31-E03012D147F0Q55113683-F456F6DA-F6FF-4D9B-90E5-1396159B23F8Q55280841-E6BE4116-E2BA-4B48-B237-FDD5F11C1BE5Q55289788-251CBED9-222E-4D13-A658-1169A0B1FC4FQ55293445-F83E00C3-8B8C-4C2F-BE19-BBF447F71AB5Q55718075-4B533F58-7FB3-415C-8E63-87976104F3F7Q57494425-CF5B64CA-A800-4E40-9CA2-FB999BFA5FE9Q57565630-583D3BDF-3DA7-445B-B686-521A54601D7AQ58780145-33D18E58-F9BA-47BC-9EC1-C30079C1CC8E
P2860
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
@en
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
@nl
type
label
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
@en
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
@nl
prefLabel
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
@en
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
@nl
P2093
P2860
P1476
Proton-pump inhibitors and risk of fractures: an update meta-analysis.
@en
P2093
P2860
P2888
P304
P356
10.1007/S00198-015-3365-X
P407
P577
2016-01-01T00:00:00Z
P6179
1051555156